Oral chemotherapy pill tested for advanced breast cancer

NCT ID NCT06500494

Ongoing Disease control Sponsor: Pierre Fabre Medicament Source: ClinicalTrials.gov ↗

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This study looks at how well oral vinorelbine, a chemotherapy pill, works in women with advanced breast cancer. It includes women who have already taken the drug or are starting it now. Researchers track how long the cancer stays under control and how patients feel during treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: oral vinorelbine (Navelbine)
What this could lead to: If results are positive, this could confirm oral vinorelbine as a reliable chemotherapy option for advanced breast cancer, offering a convenient at-home treatment.
What could go wrong: This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by patient selection or other treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED BREAST CANCER

Contacts and locations

Locations

Azienda Ospedaliera San Gerardo U.O. Oncologia Medica

Monza, 20052, Italy
Centre Hospitalo-Universitaire Mustapha, Hopital Mustapha, Place du 1er Mai 1945, Sidi M'Hamed

Algiers, 16000, Algeria
Tianjing Medical University Cancer Institute & Hospital

Tianjin, Tianjin Municipality, 360060, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.